HiPep Laboratories, Inc. participated in the 58th Annual Meeting of the Japanese Association of Clinical Laboratory Systems (JCLS2026) and the accompanying JaCLaS EXPO2026, held at Kobe International Conference Center, Japan, from October 8 to 10, 2026.
At the meeting, our researchers delivered two oral presentations on PepTenChip®, our proprietary peptide microarray technology, covering both its fundamental technology and its applications in clinical testing and diagnostics.
Presentations
1. Development of a Peptide Microarray Using an Amorphous Carbon Substrate Based on a Novel Principle
Presenter: Atsushi Kitagawa
This presentation introduced the development of a peptide microarray using an amorphous carbon substrate based on a novel principle, including the underlying principles, materials, methods, and key features of the technology supporting PepTenChip®.
2. Applications of a Novel Bio-Detection Technology Using Peptide Microarrays to Clinical Tests
Presenter: Yuki Tominaga
This presentation focused on applications of our novel bio-detection technology based on peptide microarrays to clinical testing and diagnostics, highlighting our efforts to translate the underlying technology of PepTenChip® into diagnostic applications.
Event Information
- Event: 58th Annual Meeting of the Japanese Association of Clinical Laboratory Systems (JCLS2026)
- Concurrent Exhibition: JaCLaS EXPO2026
- Dates: October 8–10, 2026
- Venue: Kobe International Conference Center, Kobe, Japan
HiPep Laboratories will continue advancing the fundamental technology and diagnostic applications of PepTenChip®, with the aim of bringing innovative bio-detection technologies closer to practical use.